Epidemiology and factors associated with candidaemia following Clostridium difficile infection in adults within metropolitan Atlanta, 2009-2013.

Vallabhaneni, S; Almendares, O; Farley, M M; Reno, J; Smith, Z T; Stein, B; Magill, S S; Smith, R M; Cleveland, A A; Lessa, F C

Vallabhaneni, S; Almendares, O; Farley, M M; Reno, J; Smith, Z T; Stein, B; Magill, S S; Smith, R M; Cleveland, A A; Lessa, F C.

Afiliação

Vallabhaneni S; Epidemic Intelligence Service Centers for Disease Control and Prevention,Atlanta,GA,USA.
Almendares O; Georgia Emerging Infections Program,Atlanta,GA,USA.
Farley MM; Emory University School of Medicine,Department of Medicine,Atlanta,GA,USA.
Reno J; Georgia Emerging Infections Program,Atlanta,GA,USA.
Smith ZT; Georgia Emerging Infections Program,Atlanta,GA,USA.
Stein B; Georgia Emerging Infections Program,Atlanta,GA,USA.
Magill SS; Division of Healthcare Quality Promotion,National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention,Atlanta,GA,USA.
Smith RM; Division of Foodborne Waterborne and Environmental Diseases,National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention,Atlanta,GA,USA.
Cleveland AA; Division of Foodborne Waterborne and Environmental Diseases,National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention,Atlanta,GA,USA.
Lessa FC; Division of Healthcare Quality Promotion,National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention,Atlanta,GA,USA.

Epidemiol Infect ; 144(7): 1440-4, 2016 05.

Article em En | MEDLINE | ID: mdl-26608090

ABSTRACT

ABSTRACT

We assessed prevalence of and risk factors for candidaemia following Clostridium difficile infection (CDI) using longitudinal population-based surveillance. Of 13 615 adults with CDI, 113 (0·8%) developed candidaemia in the 120 days following CDI. In a matched case-control analysis, severe CDI and CDI treatment with vancomycin + metronidazole were associated with development of candidaemia following CDI.

Assuntos

Antibacterianos/uso terapêutico; Candida/fisiologia; Candidemia/epidemiologia; Clostridioides difficile/fisiologia; Infecções por Clostridium/epidemiologia; Metronidazol/uso terapêutico; Vancomicina/uso terapêutico; Adolescente; Adulto; Idoso; Candidemia/tratamento farmacológico; Candidemia/microbiologia; Estudos de Casos e Controles; Infecções por Clostridium/complicações; Infecções por Clostridium/tratamento farmacológico; Infecções por Clostridium/microbiologia; Feminino; Georgia/epidemiologia; Humanos; Estudos Longitudinais; Masculino; Pessoa de Meia-Idade; Prevalência; Fatores de Risco; Adulto Jovem

Palavras-chave

CDI treatment; Candidaemia; Clostridium difficile infection; co-infection; severe CDI

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Assunto principal: Candida / Vancomicina / Clostridioides difficile / Infecções por Clostridium / Candidemia / Metronidazol / Antibacterianos Tipo de estudo: Etiology_studies / Observational_studies / Prevalence_studies / Risk_factors_studies / Screening_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Epidemiol Infect Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google